Trials / Completed
CompletedNCT05485922
Performance of a Single-use Intermittent Micro-hole Zone Catheter
A Randomized, Open-labelled, Crossover Study Confirming Performance of a Single-use Intermittent Micro-hole Zone Catheter in a Population of Adult Male Intermittent Catheter Users
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Coloplast A/S · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomized, controlled crossover study was to assess the performance of a new micro-hole zone catheter compared to a conventional 2-eyelet catheter in 42 male intermittent catheter users. The main objective of this study was to demonstrate superiority of the micro-hole zone catheter in terms of number of flow-stop episodes and residual volume at first flow-stop, with the catheterization performed by a health care professional in a hospital setting compared to a conventional two-eyelet catheter.
Detailed description
The investigation was a single-centre, randomized, controlled crossover study including 42 male participants comparing the performance of two intermittent catheters (IC). The study included an information visit (visit 0) and two test visits (visit 1 and 2) in which one catheterization with either the investigational device or the comparator device, according to a randomization scheme, was performed by a health care professional in a hospital setting assessing flow stop episodes, bladder emptying and hematuria. There were 4-14 days between each test visit (visit 1 and 2) and visit 0 and 1 could be held on the same day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Investigational device - intermittent catheter with a micro-hole zone | The investigational device was a urinary catheter for bladder drainage through the urethra. The product is for intermittent use. |
| DEVICE | Comparator device -VaPro intermittent catheter | The comparator device is a urinary catheter for bladder drainage through the urethra. The product is for intermittent use. |
Timeline
- Start date
- 2022-09-23
- Primary completion
- 2022-11-04
- Completion
- 2022-11-04
- First posted
- 2022-08-03
- Last updated
- 2025-03-05
- Results posted
- 2025-03-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05485922. Inclusion in this directory is not an endorsement.